Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

ADVERTISEMENT

November 2019

Feature

Perspectives
Integrating Palliative Care Into the Oncology Care Model via Clinical Pathways
11/18/2019
Nikita V Baclig, MD, MPH
Joshua M Liao, MD, MSc, FACP
Abstract: Participants in the Oncology Care Model (OCM) have both the opportunity and need to drive performance by building upon strong historical foundations in oncology clinical pathways and by promoting outcomes...
Abstract: Participants in the Oncology Care Model (OCM) have both the opportunity and need to drive performance by building upon strong historical foundations in oncology clinical pathways and by promoting outcomes...
...
11/18/2019
Journal of Clinical Pathways
From the Field
A Community Practice Perspective on Implementation of Nursing Triage Pathways
11/18/2019
Anne Marie Fraley Rainey, MSN, RN, CHC
Abstract: Clearview Cancer Institute is a private, community practice participating in the Oncology Care Model, an innovative pilot project sponsored by the Center for Medicare and Medicaid Innovation. Over the...
Abstract: Clearview Cancer Institute is a private, community practice participating in the Oncology Care Model, an innovative pilot project sponsored by the Center for Medicare and Medicaid Innovation. Over the...
...
11/18/2019
Journal of Clinical Pathways

Column

Clinical Pathways GPS
Speaker Pelosi’s Plan to Lower Drug Costs
11/18/2019
Matthew Pakizegee, PharmD, MS
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
As total cost of care increasingly becomes a major issue in the United States, both market solutions like clinical pathways and government solutions such as drug pricing regulations are being proposed. Each solution...
As total cost of care increasingly becomes a major issue in the United States, both market solutions like clinical pathways and government solutions such as drug pricing regulations are being proposed. Each solution...
As...
11/18/2019
Journal of Clinical Pathways
Pharma Insights
How Development of Gene Therapies Impact Decisions on Their Place in Therapy
11/18/2019
Larry Blandford, PharmD—Column Editor
Aaron Burke
Gene therapy has sparked significant interest among researchers, health care providers, and patients because it offers the tantalizing possibility of a cure, particularly for rare diseases with a genetic basis. While...
Gene therapy has sparked significant interest among researchers, health care providers, and patients because it offers the tantalizing possibility of a cure, particularly for rare diseases with a genetic basis. While...
Gene...
11/18/2019
Journal of Clinical Pathways
Trending From ACCC
ACCC Spotlights Strategies to Improve Care for Senior Adults With Cancer
11/18/2019
JCP Editors
By 2030, it is estimated that 70% of cancers in the United States will be diagnosed in older adults, and by 2040 nearly three-fourths (73%) of the country’s cancer survivors will be aged 65 years or older.1,2 This...
By 2030, it is estimated that 70% of cancers in the United States will be diagnosed in older adults, and by 2040 nearly three-fourths (73%) of the country’s cancer survivors will be aged 65 years or older.1,2 This...
By...
11/18/2019
Journal of Clinical Pathways
Editor's Page
More Comprehensive Pathways to Support Success in Value-Based Reimbursement Models
11/18/2019
Winston Wong, PharmD, Editor-in-Chief
Clinical pathways—defined as structured, multidisciplinary care plans that incorporate evidence-based guidelines and protocols to standardize care—represent a natural strategy for achieving success in the Oncology...
Clinical pathways—defined as structured, multidisciplinary care plans that incorporate evidence-based guidelines and protocols to standardize care—represent a natural strategy for achieving success in the Oncology...
...
11/18/2019
Journal of Clinical Pathways
Column
An Update on Treatment Approaches Across the Multiple Myeloma Spectrum
11/18/2019
Jonathan L Kaufman, MD
This section called “CME Corner,” highlights, when available, relevant continuing medical education (CME) opportunities deemed to be of use to readers. Articles include an overview of a specific area where key...
This section called “CME Corner,” highlights, when available, relevant continuing medical education (CME) opportunities deemed to be of use to readers. Articles include an overview of a specific area where key...
This...
11/18/2019
Journal of Clinical Pathways

Insights

Interview
Patient-Centered Pathways at Yale Cancer Center
11/18/2019
JCP Editors
Earlier this year, Kerin Adelson, MD, chief quality officer and deputy chief medical officer for Yale Cancer Center and Smilow Cancer Hospital, shared her experiences leading the implementation of Via Pathways at...
Earlier this year, Kerin Adelson, MD, chief quality officer and deputy chief medical officer for Yale Cancer Center and Smilow Cancer Hospital, shared her experiences leading the implementation of Via Pathways at...
...
11/18/2019
Journal of Clinical Pathways

Department

Pathways in Practice
Development and Use of a Pathway for Chronic Lymphocytic Leukemia: The US Oncology Experience
11/18/2019
JCP Editors
*/ /*-->*/ In this journal section, we speak with cancer care practitioners about their clinical pathways and the pathways programs being used in their practice, how they are being applied in a particular...
*/ /*-->*/ In this journal section, we speak with cancer care practitioners about their clinical pathways and the pathways programs being used in their practice, how they are being applied in a particular...
...
11/18/2019
Journal of Clinical Pathways
Research in Review
Research in Review
11/18/2019
JCP Editors
Improving Treatment Adherence Through a CML Specialty Pharmacy Service Model A two-way clinical messaging platform in a specialty pharmacy service model may positively affect adherence outcomes in patients with...
Improving Treatment Adherence Through a CML Specialty Pharmacy Service Model A two-way clinical messaging platform in a specialty pharmacy service model may positively affect adherence outcomes in patients with...
...
11/18/2019
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP May/June 2024 Issue

Current Issue

June 2024
Volume 10
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Winston Wong, PharmD
Gordon Kuntz
Robin T Zon, MD, FACP, FASCO
2021 Care Pathways Working Group
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
Special Report
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
01/14/2021
01/14/2021
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Volume 5

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement